PureTech Health (PRTC) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Apr 2018 04:17 PM
RNS
Result of Meeting
19 Mar 2018 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
16 Mar 2018 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
15 Mar 2018 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
15 Mar 2018 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
14 Mar 2018 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
14 Mar 2018 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
13 Mar 2018 10:54 AM
RNS
Circular Publication and Notice of General Meeting
13 Mar 2018 07:35 AM
RNS
Results of Placing
12 Mar 2018 04:54 PM
RNS
Proposed Placing and Notice of General Meeting
01 Mar 2018 07:00 AM
RNS
Gelesis Raises $30M; Prepares for Potential Launch
20 Feb 2018 07:00 AM
RNS
Trading Statement
31 Jan 2018 07:00 AM
RNS
PRTC resTORbio closes IPO, adds $13M to $85M raise
26 Jan 2018 07:00 AM
RNS
PureTech's resTORbio successfully lists on NASDAQ
03 Jan 2018 07:00 AM
RNS
PRTC's resTORbio Adds Senior Biogen Exec to Board
02 Jan 2018 07:00 AM
RNS
PRTC's resTORbio Files Public S1 for NASDAQ IPO
19 Dec 2017 07:00 AM
RNS
Lilly to invest $5M in PureTech's Entrega
13 Dec 2017 07:00 AM
RNS
PureTech's Vedanta Granted Four New US Patents
11 Dec 2017 07:00 AM
RNS
PureTech's resTORbio Adds Paul Fonteyne to Board
07 Dec 2017 07:00 AM
RNS
PRTC: Vedanta Enters Clinic/FDA Orphan Designation
05 Dec 2017 03:14 PM
RNS
Increase of Holdings in Company
05 Dec 2017 07:00 AM
RNS
PRTC's resTORbio Files IPO Registration Statement
04 Dec 2017 07:00 AM
RNS
PureTech's Akili Pivotal ADHD Trial Successful
30 Nov 2017 07:00 AM
RNS
PureTech's resTORbio Raises $40 Million
29 Nov 2017 07:00 AM
RNS
PRTC's Vedanta Grows ImmunoOncology Collaborations
22 Nov 2017 07:00 AM
RNS
PureTech to Present at Piper Jaffray Conference
20 Nov 2017 07:00 AM
RNS
PRTC's Clinical-Stage Anti-Aging Compound Advances
09 Nov 2017 07:00 AM
RNS
PRTC to Present at Jefferies 2017 in London
03 Nov 2017 07:00 AM
RNS
PRTC: Vedanta Gets $5.4M for Antibiotic Resistance
01 Nov 2017 07:00 AM
RNS
PRTC's Vedanta Licenses Microbiome IO Candidates
20 Oct 2017 12:07 PM
RNS
Second Price Monitoring Extn
20 Oct 2017 12:02 PM
RNS
Price Monitoring Extension
27 Sep 2017 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
26 Sep 2017 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
25 Sep 2017 07:00 AM
RNS
Research Update PRTC Gelesis Shows Efficacy/Safety
20 Sep 2017 07:00 AM
RNS
PRTC Notes IP For Health Assessments from Speech
19 Sep 2017 07:00 AM
RNS
PureTech Licenses Milk-Derived Exosome Technology
15 Sep 2017 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
07 Sep 2017 05:00 PM
RNS
Director/PDMR Shareholding
04 Sep 2017 07:00 AM
RNS
Director/PDMR Shareholding
31 Aug 2017 07:00 AM
RNS
Total Voting Rights
30 Aug 2017 07:00 AM
RNS
PureTech Health plc Half-year Report
29 Aug 2017 07:00 AM
RNS
PureTech Licenses Glyph Lymphatic Technology
25 Aug 2017 05:11 PM
RNS
Additional Listing
02 Aug 2017 07:00 AM
RNS
Notice of Results
31 Jul 2017 07:00 AM
RNS
Director/PDMR Shareholding
13 Jul 2017 07:00 AM
RNS
PureTech Presents Inflammation-Targeting Data
12 Jul 2017 07:00 AM
RNS
PRTC's Gelesis Notes Last Patient in Pivotal Study
03 Jul 2017 07:00 AM
RNS
PDMR DEALING - PURCHASE OF SHARES
28 Jun 2017 02:08 PM
RNS
PRTC's Akili Names Former Cubist CEO Exec Chairman

PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.

PureTech share price launched at 178p in 2015.

UK 100

Latest directors dealings